4//SEC Filing
KURIYEL RALF 4
Accession 0000950170-25-031591
CIK 0000730272other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 1:41 PM ET
Size
8.8 KB
Accession
0000950170-25-031591
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
KURIYEL RALF
Senior VP, R&D
Transactions
- Award
Stock Option (Right to Buy)
2025-03-03+4,542→ 4,542 totalExercise: $155.38Exp: 2035-03-03→ Common Stock (4,542 underlying) - Award
Common Stock
2025-03-03+4,826→ 16,448 total - Tax Payment
Common Stock
2025-03-03$155.38/sh−386$59,977→ 16,062 total
Footnotes (3)
- [F1]Mr. Kuriyel was awarded 4,826 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual instalments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
- [F3]One third of the stock options will vest and become exercisable annually on March 3, 2026, March 3, 2027, and March 3, 2028.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeother
Related Parties
1- filerCIK 0001733143
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 1:41 PM ET
- Size
- 8.8 KB